Combined gamma conglutin and lupanine treatment exhibits in vivo an enhanced antidiabetic effect by modulating the liver gene expression profile

HIGHLIGHTS

• who: Paloma Lucu00eda Guerra-u00c1vila and colleagues from the Departamento de Biologu00eda Molecular Genu00f3mica, Centro Universitario de Ciencias de la, Instituto de, Universidad de, ColIndependencia, Jalisco, Mexico have published the research work: Combined Gamma Conglutin and Lupanine Treatment Exhibits In Vivo an Enhanced Antidiabetic Effect by Modulating the Liver Gene Expression Profile, in the Journal: Pharmaceuticals 2023, 117 of 29/Nov/2022
• what: The authors aimed to evaluate different dose combinations of Cu03b3 and by the oral glucose tolerance test (OGTT) to identify the higher antidiabetic effect on a T2D rat model. For the first . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.